Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $22.0000 (-6.38%) ($21.5000 - $23.1000) on Thu. Nov. 16, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 11.84% (three month average) | RSI | 48 | Latest Price | $22.0000(-6.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.1% a day on average for past five trading days. | Weekly Trend | CAPR advances 3.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWG(8%) SKYY(8%) TBT(8%) XLF(8%) ARKK(7%) | Factors Impacting CAPR price | CAPR will decline at least -5.92% in a week (0% probabilities). TLT(-8%) GLD(-8%) GDX(-8%) SLV(-6%) SIL(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.92% (StdDev 11.84%) | Hourly BBV | 0 () | Intraday Trend | -4.3% | | | |
|
Resistance Level | $23.37 | 5 Day Moving Average | $24.94(-11.79%) | 10 Day Moving Average | $23.44(-6.14%) | 20 Day Moving Average | $23.37(-5.86%) | To recent high | -36.2% | To recent low | 126.8% | Market Cap | $433m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |